FGFR1, a transmembrane receptor tyrosine kinase for fibroblast growth factors is constitutively activated by chromosomal translocations in an atypical stem cell myeloproliferative disorder. The FGFR1 tyrosine domain is fused to dimerization domains encoded by four alternative genes: FOP at 6q27, CEP110 at 9q33, FIM/ZNF198 at 13q12, and BCR at 22q11. In this study, we report the molecular cloning of the t(8;19)(p12;q13.3), the fifth translocation associated with this syndrome. Reverse transcriptase polymerase chain reaction analysis and fluorescence in situ hybridization (FISH) demonstrated that the translocation resulted in a long terminal repeat of human endogenous retrovirus gene (HERV-K)/fibroblast growth factor receptor 1 (FGFR1) fusion transcript that incorporated 5' sequences from HERV-K fused in frame to 3' FGFR1 sequences encoding the kinase domain.
Introduction
Neoplastic disorders arise due to acquired, and sometimes inherited, genetic abnormalities.
1 Recurrent translocations in malignancy have served as signposts to identify genes critical to the molecular pathogenesis of the disease. In the stem-cell myeloproliferative (MPD) linked to 8p12 chromosomal region, the recurrent translocations involve the FGFR1 gene, which encodes one of the tyrosine kinase receptors for fibroblast growth factors. 2 This syndrome is characterized by myeloid hyperplasia with frequent peripheral blood eosinophilia, and B-or T-cell lymphoblastic leukemia/lymphoma; it generally progresses to acute myeloid leukemia. 3 To date, three FGFR1 partner genes have been cloned, FOP at 6q27, 4 CEP110 at 9q33, 5 and FIM/ZNF198 at 13q12. [6] [7] [8] [9] Four other translocations have been identified in myeloid disorders. 10 FGFR1 is also disrupted and fused to BCR in patients with chronic myeloid leukemia associated with the t(8;22). 11, 12 We have recently identified the t(8;19)(p13;q13.3) as a novel translocation involving the FGFR1 gene in a patient suffering from an atypical myeloproliferative syndrome. 13 We report here the cloning of this translocation breakpoint that fuses sequence from a human endogenous retrovirus gene of the HERV-K3 family to FGFR1 sequences encoding its entire tyrosine kinase domain.
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Study design

Patient
The clinical and cytogenetic data of the patient's case have been previously described.
13
Cloning of the t(8;19) breakpoint and identification of the fusion gene 5' RACE-PCR was done as previously described. 5 Half part of PCR products were resolved on 2% agarose gels, purified by using NucleoSpin extract kit (Macherey-Nagel, Düren, Germany), subcloned into pGEM-T vector (Promega, Madison, USA), and sequenced by Génome Express (Meylan, France). The other part of the PCR products were separated by electrophoresis on 2% agarose gel and transferred to Hybond N+ membrane (Amersham Pharmacia). A specific primer spanning the t(8;19) breakpoint (5'-TCCTGTGCGGTGTCTGCTGA-3') was used for hybridization.
FISH analysis.
Two-color FISH experiments were done on metaphase chromosome spreads from normal lymphocytes and patient's bone marrow cells as previously described.
14 DNA from BAC clone RP11-706G10 (BACPAC Resources, Children's Hospital, Oakland, California) specific to the currently identified HERV-K sequences was purified using NUCLEOBOND BAC 100 kit (Macherey-Nagel, Hoerdt, France). RT reactions were done using 2 µg of polyadenylated RNA from the patient's bone marrow cells or 5 µg of total RNA from several human tissues. Each resulting complementary DNA (or control lacking reverse transcriptase) was used as a template for PCR as previously described. 4 The following primers were used: 
Results and discussion
In a previous study, we identified FGFR1 as the chromosome 8 breakpoint gene by FISH experiments in patient's hematopoietic cells harboring t(8;19)(p12;q13.3) translocation. 13 In the current study, the chromosome 15 and HERV-K113. 16 RepeatMasker analysis demonstrated the presence of two 5' long terminal repeat (LTR) sequences (exons 2 and 4), two 3' LTR fragments (exon 3), and one LINE sequence (exon 4). An ORF of 225 bp was identified in the first 3' LTR and showed similarities with retroviral envelope protein (ORF ENV-Like, Figure 1A ). This peculiar structure is characteristic of a defective retrovirus. 17, 18 The 5' sequence of this ORF (150 bp) is fused in frame to FGFR1 sequences at nucleotide 1273 that corresponds to the beginning of exon 9
(accession no. M34185) ( Figure 1B ). 
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These results were confirmed by Southern blot analysis of the RT-PCR products by using an oligonucleotide probe specific to the fusion junction and 32 P labeled ( Figure   3B ). Sequence analysis demonstrated that the unique PCR product contained fusion of HERV-K and FGFR1 sequences as expected.
The novel HERV-K we cloned and assigned to chromosome 19q13.3 is ubiquitously expressed as revealed by RT-PCR done on various tissues ( Figure 3C ).
HERV-K are human specific, 19 characterized by their similarities with the B-type 7 mouse mammary tumor virus (MMTV) and Syrian hamster intracisternal A-type particles (IAP). 20 The human genome harbors 25 to 50 copies of endogenous retrovirus type K; some of which code for the characteristic retroviral proteins. shown that DNA damaging agents often activate transposable elements in genomes and induce gene rearrangement in leukemias. 24 We report here that in the t(8;19)(p12;q13.3) that leads to atypical myeloproliferative disorder linked to 8p12, the translocation breakpoint on chromosome 19 involved an endogenous retrovirus element. As a consequence of 8p12 chromosomal translocation with a promiscuous (heterogeneous) array of 
